AbbVie Announces U.S. FDA Granted Breakthrough Therapy Designation to Telisotuzumab Vedotin for Previously Treated Non-Small Cell Lung Cancer Pharmaceutical Investing
Bristol Myers Squibb to Present at J.P. Morgan's 40th Annual Healthcare Conference Pharmaceutical Investing
BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange under 'BCT'; Remains 'BCTX' on Nasdaq Life Science Investing
Lexaria Receives Independent Review Board Approval For DehydraTECH-CBD Human Clinical Study HYPER-H21-4 Biotech Investing
Boosh to Introduce 2 New Frozen Boosh Bowls, One Refrigerated Heat n' Eat Pouch In Q1 Life Science Investing
